{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T20:21:10Z","timestamp":1790972470533,"version":"4.1.0"},"reference-count":53,"publisher":"Oxford University Press (OUP)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2002,3,1]]},"DOI":"10.1093\/bmb\/61.1.133","type":"journal-article","created":{"date-parts":[[2002,7,26]],"date-time":"2002-07-26T22:57:29Z","timestamp":1027724249000},"page":"133-150","source":"Crossref","is-referenced-by-count":25,"title":["HIV disease and respiratory infection in children"],"prefix":"10.1093","volume":"61","author":[{"given":"Stephen M","family":"Graham","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana M","family":"Gibb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2002,3]]},"reference":[{"key":"key\n\t\t\t\t20180712074134_B1","unstructured":"Graham SM, Coulter JBS, Gilks CF. Pulmonary disease in HIV-infected African children. Int J Tuberc Lung Dis2001; 5: 12\u201323"},{"key":"key\n\t\t\t\t20180712074134_B2","doi-asserted-by":"crossref","unstructured":"Abrams EJ. Opportunistic infections and other clinical manifestations of HIV disease in children. Pediatr Clin North Am2000; 47: 79\u2013108","DOI":"10.1016\/S0031-3955(05)70196-6"},{"key":"key\n\t\t\t\t20180712074134_B3","unstructured":"UNAIDS. AIDS Epidemic Update: December 2000. Geneva: UNAIDSsWHO, 2001"},{"key":"key\n\t\t\t\t20180712074134_B4","doi-asserted-by":"crossref","unstructured":"Williams AJ, Duong T, McNally LM et al. Pneumocystis carinii pneumonia and cytomegalovirus infection in children with vertically acquired HIV infection. AIDS2001; 15: 335\u20139","DOI":"10.1097\/00002030-200102160-00006"},{"key":"key\n\t\t\t\t20180712074134_B5","doi-asserted-by":"crossref","unstructured":"Dunn DT, Newell ML, Ades AE, Peckham CS. Risk of human immunodeficiency virus type 1 transmission through breastfeeding. Lancet1992; 340: 585\u20138","DOI":"10.1016\/0140-6736(92)92115-V"},{"key":"key\n\t\t\t\t20180712074134_B6","doi-asserted-by":"crossref","unstructured":"Mandlebrot L, Le Chenadec J, Berrebi A et al. Perinatal HIV-1 transmission. Interaction between zidovudine prophylaxis and mode of delivery in the French perinatal cohort. JAMA1998; 280: 55\u201360","DOI":"10.1001\/jama.280.1.55"},{"key":"key\n\t\t\t\t20180712074134_B7","doi-asserted-by":"crossref","unstructured":"European Mode of Delivery Collaboration. Elective caesarean-section versus vaginal delivery in prevention of vertical HIV-1 transmission: a randomised clinical trial. Lancet1999; 353: 1035\u20139","DOI":"10.1016\/S0140-6736(98)08084-2"},{"key":"key\n\t\t\t\t20180712074134_B8","doi-asserted-by":"crossref","unstructured":"Doung T, Ades AE, Gibb DM et al. Falling HIV vertical transmission and disease progression rates: estimates from surveillance data in the UK and Eire. BMJ1999; 319: 1227\u20139","DOI":"10.1136\/bmj.319.7219.1227"},{"key":"key\n\t\t\t\t20180712074134_B9","unstructured":"Centres for Disease Control and Prevention (US Department of Health and Human Services). Update: perinatally acquired HIVsAIDS \u2013 United States. 1997 MMWR Morb Mortal Wkly Rep 1997; 1086\u201392"},{"key":"key\n\t\t\t\t20180712074134_B10","doi-asserted-by":"crossref","unstructured":"Ades AE, Walker J, Botting B, Parker S, Cubbitt D, Jones R. Effect of the worldwide epidemic in the United Kingdom: record linkage in anonymous neonatal seroprevalence surveys. AIDS1999; 13: 2437\u201343","DOI":"10.1097\/00002030-199912030-00016"},{"key":"key\n\t\t\t\t20180712074134_B11","doi-asserted-by":"crossref","unstructured":"Guay LA, Musoke P, Fleming T et al. Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial. Lancet1999; 354: 795\u2013802","DOI":"10.1016\/S0140-6736(99)80008-7"},{"key":"key\n\t\t\t\t20180712074134_B12","doi-asserted-by":"crossref","unstructured":"Dankner WM, Lindsey JC, Levin MJ and the Pediatric AIDS Clinical Trials Group. Correlates of opportunistic infections in children infected with the human immunodeficiency virus managed before highly active antiretroviral therapy. Pediatr Infect Dis J2001; 20: 40\u20138","DOI":"10.1097\/00006454-200101000-00008"},{"key":"key\n\t\t\t\t20180712074134_B13","doi-asserted-by":"crossref","unstructured":"DeMartino M, Tovo P-A, Balducci M et al for the Italian Registry for HIV infection in Children. Reduction in mortality with availability of antiretroviral therapy for children with perinatal HIV-1 infection. JAMA2000; 284: 190\u20137","DOI":"10.1001\/jama.284.2.190"},{"key":"key\n\t\t\t\t20180712074134_B14","doi-asserted-by":"crossref","unstructured":"Paediatric European Network for Treatment of AIDS (PENTA). Five-year follow-up of vertically HIV-infected children in a randomized double-blind controlled trial of immediate versus deferred zidovudine: the PENTA 1 trial. Arch Dis Child2001; 84: 230\u20136","DOI":"10.1136\/adc.84.3.230"},{"key":"key\n\t\t\t\t20180712074134_B15","unstructured":"Centers for Disease Control and Prevention. Revised guidelines for prophylaxis against Pneumocystis carinii pneumonia for children infected with or perinatally exposed to human immunodeficiency virus. MMWR Morb Mortal Wkly Rep1995; 44 (RR-4): 1\u201311"},{"key":"key\n\t\t\t\t20180712074134_B16","doi-asserted-by":"crossref","unstructured":"Spira R, Lepage P, Msellati P et al. Natural history of human immunodeficiency virus type 1 infection in children: a five-year prospective study in Rwanda. Pediatrics1999; 104: e56","DOI":"10.1542\/peds.104.5.e56"},{"key":"key\n\t\t\t\t20180712074134_B17","doi-asserted-by":"crossref","unstructured":"Taha TE, Graham SM, Kumwenda NI et al. Morbidity among HIV-infected and uninfected African children. Pediatrics2000; 106: e77","DOI":"10.1542\/peds.106.6.e77"},{"key":"key\n\t\t\t\t20180712074134_B18","doi-asserted-by":"crossref","unstructured":"Lucas SB, Peacock CS, Hounnou A et al. Disease in children infected with HIV in Abidjan, Cote d'Ivoire. BMJ1996; 312: 335\u20138","DOI":"10.1136\/bmj.312.7027.335"},{"key":"key\n\t\t\t\t20180712074134_B19","doi-asserted-by":"crossref","unstructured":"Ikeogu MO, Wolf B, Mathe S. Pulmonary manifestations in HIV seropositivity and malnutrition in Zimbabwe. Arch Dis Child1997; 76: 124\u20138","DOI":"10.1136\/adc.76.2.124"},{"key":"key\n\t\t\t\t20180712074134_B20","doi-asserted-by":"crossref","unstructured":"Jeena PM, Coovadia HM, Chrystal V. Pneumocystis carinii and cytomegalovirus infections in severely ill, HIV-infected African infants. Ann Trop Paediatr1997; 16: 361\u20138","DOI":"10.1080\/02724936.1996.11747852"},{"key":"key\n\t\t\t\t20180712074134_B21","doi-asserted-by":"crossref","unstructured":"Van Dyke RB. Opportunistic infections in HIV-infected children. Semin Pediatr Infect Dis1995; 6: 10\u20136","DOI":"10.1016\/S1045-1870(05)80018-4"},{"key":"key\n\t\t\t\t20180712074134_B22","doi-asserted-by":"crossref","unstructured":"Sharland M, Gibb DM, Holland F. Respiratory morbidity from lymphocytic interstitial pneumonitis (LIP) in vertically acquired HIV-1 infection. Arch Dis Child1997; 76: 334\u20137","DOI":"10.1136\/adc.76.4.334"},{"key":"key\n\t\t\t\t20180712074134_B23","doi-asserted-by":"crossref","unstructured":"Usen S, Adegbola R, Mulholland K et al. Epidemiology of invasive pneumococcal disease in the Western Region, The Gambia. Pediatr Infect Dis J1998; 17: 23\u20138","DOI":"10.1097\/00006454-199801000-00006"},{"key":"key\n\t\t\t\t20180712074134_B24","doi-asserted-by":"crossref","unstructured":"Shann F. The management of pneumonia in children in developing countries. Clin Infect Dis1995; 21 (Suppl 3): S218\u201325","DOI":"10.1093\/clind\/21.Supplement_3.S218"},{"key":"key\n\t\t\t\t20180712074134_B25","doi-asserted-by":"crossref","unstructured":"Madhi SA, Petersen K, Madhi A, Khoosal M, Klugman KP. Increased disease burden and antibiotic resistance of bacteria causing severe community-acquired lower respiratory tract infections in human immunodeficiency type 1-infected children. Clin Infect Dis2000; 31: 170\u20136","DOI":"10.1086\/313925"},{"key":"key\n\t\t\t\t20180712074134_B26","doi-asserted-by":"crossref","unstructured":"Zar H, Hanslo D, Tannebaum E et al. Aetiology and outcome of pneumonia in human immunodeficiency virus-infected children hospitalized in South Africa. Acta Paediatr2001; 90: 119\u201325","DOI":"10.1111\/j.1651-2227.2001.tb00270.x"},{"key":"key\n\t\t\t\t20180712074134_B27","doi-asserted-by":"crossref","unstructured":"Graham SM, Mtitimila EI, Kamanga HS, Walsh AL, Hart CA, Molyneux ME. The clinical presentation and outcome of Pneumocystis carinii pneumonia in Malawian children. Lancet2000; 355: 369\u201373","DOI":"10.1016\/S0140-6736(98)11074-7"},{"key":"key\n\t\t\t\t20180712074134_B28","doi-asserted-by":"crossref","unstructured":"Graham SM, Molyneux EM, Walsh AL, Cheesbrough JS, Molyneux ME, Hart CA. Non-typhoidal Salmonella infections of children in tropical Africa. Pediatr Infect Dis J2000; 19: 1189\u201396","DOI":"10.1097\/00006454-200012000-00016"},{"key":"key\n\t\t\t\t20180712074134_B29","doi-asserted-by":"crossref","unstructured":"Madhi SA, Petersen K, Madhi A, Wasas A, Klugman KP. Impact of human immunodeficiency virus type 1 on the disease spectrum of Streptococcus pneumoniae in South African children. Pediatr Infect Dis J2000; 19: 1141\u20137","DOI":"10.1097\/00006454-200012000-00004"},{"key":"key\n\t\t\t\t20180712074134_B30","doi-asserted-by":"crossref","unstructured":"Gibb DM, Spoulou V, Giacomelli A et al. Antibody responses to Haemophilus influenzae type b and Streptococcus pneumoniae vaccines in children with human immunodeficiency virus infection. Pediatr Infect Dis J1995; 14: 129\u201335","DOI":"10.1097\/00006454-199502000-00009"},{"key":"key\n\t\t\t\t20180712074134_B31","doi-asserted-by":"crossref","unstructured":"French N, Nakiyingi J, Carpenter LM et al. A double-blind, randomised and placebo controlled trial of 23-valent pneumococcal polysaccharide vaccine in HIV-1 infected Ugandan adults. Lancet2000; 355: 2106\u201311","DOI":"10.1016\/S0140-6736(00)02377-1"},{"key":"key\n\t\t\t\t20180712074134_B32","doi-asserted-by":"crossref","unstructured":"Shinefield HR, Black S. Efficacy of pneumococcal conjugate vaccines in large scale field trials. Pediatr Infect Dis J2000; 19: 394\u20137","DOI":"10.1097\/00006454-200004000-00036"},{"key":"key\n\t\t\t\t20180712074134_B33","doi-asserted-by":"crossref","unstructured":"Zar HJ, Dechaboon A, Hanslo D, Apolles P, Magnus K, Hussey G. Pneumocystis carinii pneumonia in South African children with human immunodeficiency virus. Pediatr Infect Dis J2000; 19: 603\u20137","DOI":"10.1097\/00006454-200007000-00004"},{"key":"key\n\t\t\t\t20180712074134_B34","doi-asserted-by":"crossref","unstructured":"Jensen AM, Lundgren JD, Benfield T, Nielsen TL, Vestbo J. Does cytomegalovirus predict a poor prognosis in Pneumocystis carinii pneumonia treated with corticosteroids? A note for caution. Chest1995, 108: 411\u20134","DOI":"10.1378\/chest.108.2.411"},{"key":"key\n\t\t\t\t20180712074134_B35","unstructured":"WHO\/UNAIDS Secretariat. Provisional WHO\/UNAIDS Secretariat recommendations on the use of cotrimoxazole prophylaxis in adults and children living with HIV\/AIDS in Africa. Geneva: UNAIDS, 2000"},{"key":"key\n\t\t\t\t20180712074134_B36","doi-asserted-by":"crossref","unstructured":"Gibb DM, Davison CF, Holland FJ, Walters S, Novelli V, Mok J. Pneumocystis carinii pneumonia in vertically acquired HIV infection in the British Isles. Arch Dis Child1994; 70: 241\u20134","DOI":"10.1136\/adc.70.3.241"},{"key":"key\n\t\t\t\t20180712074134_B37","doi-asserted-by":"crossref","unstructured":"Simonds RJ, Oxtoby MJ, Caldwell MB, Gwinn ML, Rogers MF. Pneumocystis carinii pneumonia among US children with perinatally acquired HIV infection. JAMA1993; 270: 470\u20133","DOI":"10.1001\/jama.270.4.470"},{"key":"key\n\t\t\t\t20180712074134_B38","unstructured":"Sheikh S, Bakshi SS, Pahwa SG. Outcome and survival in HIV-infected infants with Pneumocystis carinii pneumonia and respiratory failure. Pediatr AIDS HIV Infect1996; 7: 155\u201363"},{"key":"key\n\t\t\t\t20180712074134_B39","doi-asserted-by":"crossref","unstructured":"Chokephaibulkit K, Wanachiwanawin D, Chearskul S et al. Pneumocystis carinii severe pneumonia among human immunodeficiency virus-infected children in Thailand: the effect of a primary prophylaxis strategy. Pediatr Infect Dis J1999; 18: 147\u201352","DOI":"10.1097\/00006454-199902000-00012"},{"key":"key\n\t\t\t\t20180712074134_B40","unstructured":"Lyall EGH, Head S, Walters MDS, Tudor-Williams G. Baby cocktail \u2013 a palatable four drug combo for HIV infected infants [Abstract]. AIDS2000; 14 (Suppl 4): P212"},{"key":"key\n\t\t\t\t20180712074134_B41","doi-asserted-by":"crossref","unstructured":"The National Institute of Child Health and Human Developments Intravenous Immunoglobulin Study Group. Intravenous immune globulin for the prevention of bacterial infections in children with symptomatic human immunodeficiency virus infection. N Engl J Med1991; 325: 73\u201380","DOI":"10.1056\/NEJM199107113250201"},{"key":"key\n\t\t\t\t20180712074134_B42","doi-asserted-by":"crossref","unstructured":"Spector SA, Gelber RD, McGrath N et al. A controlled trial of intravenous immune globulin for the prevention of serious bacterial infections in children receiving zidovudine for advanced human immunodeficiency virus infection. Pediatric AIDS Clinical Trials Group. N Engl J Med1994; 331: 1181\u20137","DOI":"10.1056\/NEJM199411033311802"},{"key":"key\n\t\t\t\t20180712074134_B43","doi-asserted-by":"crossref","unstructured":"Wiktor SZ, Sassan-Morokro M, Grant AD et al. Efficacy of trimethoprim-sulphamethoxazole prophylaxis to decrease morbidity and mortality in HIV-1-infected patients with tuberculosis in Abidjan, Cote d'Ivoire: a randomised controlled trial. Lancet1999; 353: 1469\u201375","DOI":"10.1016\/S0140-6736(99)03465-0"},{"key":"key\n\t\t\t\t20180712074134_B44","doi-asserted-by":"crossref","unstructured":"Anglaret X, Chene G, Attia A et al. Early chemoprophylaxis with trimethoprim-sulphamethoxazole for HIV-1-infected adults in Abidjan, Cote d'Ivoire: a randomised trial. Lancet1999; 353: 1463\u201368","DOI":"10.1016\/S0140-6736(98)07399-1"},{"key":"key\n\t\t\t\t20180712074134_B45","doi-asserted-by":"crossref","unstructured":"Anglaret X, Sylla-Koko F, Bonard D et al. Susceptibilities to co-trimoxazole of pathogens isolated from blood and stool specimens in Abidjan, Ivory Coast, 1994\u20131996. J Clin Microbiol1997; 35: 1915","DOI":"10.1128\/JCM.35.7.1915-1915.1997"},{"key":"key\n\t\t\t\t20180712074134_B46","doi-asserted-by":"crossref","unstructured":"Madhi SA, Schoub B, Simmank K, Blackburn N, Klugman KP. Increased burden of respiratory viral associated severe lower respiratory tract infections in children with human immunodeficiency virus type-1. J Pediatr2000; 137: 78\u201384","DOI":"10.1067\/mpd.2000.105350"},{"key":"key\n\t\t\t\t20180712074134_B47","doi-asserted-by":"crossref","unstructured":"Sension MG, Quinn TC, Makowitz LE, Batter V, Heyward WL. Measles in hospitalised African children with human immunodeficiency virus. Am J Dis Child1988; 165: 1271\u20132","DOI":"10.1001\/archpedi.1988.02150120025021"},{"key":"key\n\t\t\t\t20180712074134_B48","doi-asserted-by":"crossref","unstructured":"Mukadi YD, Wiktor SZ, Coulibaly I-M et al. Impact of HIV infection on the development, clinical presentation and outcome of tuberculosis among children in Abidjan, Cote d'Ivoire. AIDS1997; 11: 1151\u20138","DOI":"10.1097\/00002030-199709000-00011"},{"key":"key\n\t\t\t\t20180712074134_B49","doi-asserted-by":"crossref","unstructured":"Kiwanuka J, Graham SM, Coulter JBS et al. Diagnosis of pulmonary tuberculosis in children in an HIV endemic area in Malawi. Ann Trop Paediatr2001; 21: 5\u201314","DOI":"10.1080\/02724930125056"},{"key":"key\n\t\t\t\t20180712074134_B50","doi-asserted-by":"crossref","unstructured":"Rutstein RM, Cobb P, McGowan KL, Pinto-Martin J, Starr SE. Mycobacterium avium-intracellulare complex infection in HIV-infected children. AIDS1993; 7: 507\u201312","DOI":"10.1097\/00002030-199304000-00009"},{"key":"key\n\t\t\t\t20180712074134_B51","doi-asserted-by":"crossref","unstructured":"Jeena PM, Coovadia HM, Thula SA, Blythe D, Buckels NJ, Chetty R. Persistent and chronic lung disease in HIV-1 infected and uninfected African children. AIDS1998; 12: 1185\u201393","DOI":"10.1097\/00002030-199810000-00011"},{"key":"key\n\t\t\t\t20180712074134_B52","doi-asserted-by":"crossref","unstructured":"Evans JA, Gibb DM, Holland FJ, Tookey PA, Prichard J, Ades AE. Malignancies in children with HIV infection acquired from mother-to-child transmission in the United Kingdom. Arch Dis Child1997; 76: 330\u20134","DOI":"10.1136\/adc.76.4.330"},{"key":"key\n\t\t\t\t20180712074134_B53","doi-asserted-by":"crossref","unstructured":"Newton R, Zeigler J, Beral V et al. A case-control study of human immunodeficiency virus infection and cancer in adults and children residing in Kampala, Uganda. Int J Cancer2001; 92: 622\u20137","DOI":"10.1002\/1097-0215(20010601)92:5<622::AID-IJC1256>3.0.CO;2-K"}],"container-title":["British Medical Bulletin"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/bmb\/article-pdf\/61\/1\/133\/25151717\/133.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,3,4]],"date-time":"2020-03-04T09:39:40Z","timestamp":1583314780000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bmb\/article\/61\/1\/133\/286887"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,3,1]]},"references-count":53,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2002,3]]},"published-print":{"date-parts":[[2002,3,1]]}},"URL":"https:\/\/doi.org\/10.1093\/bmb\/61.1.133","relation":{},"ISSN":["1471-8391","0007-1420"],"issn-type":[{"value":"1471-8391","type":"electronic"},{"value":"0007-1420","type":"print"}],"subject":[],"published-other":{"date-parts":[[2002,3]]},"published":{"date-parts":[[2002,3,1]]}}}